Healthcare Services

Urticaria Market Growth Outlook and Forecast Through 2030

April 28, 2026April 30, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Urticaria Market Expected To Change From 2026 To 2030?

The urticaria market has experienced significant expansion recently. It is projected to increase from $4.76 billion in 2025 to $5.61 billion in 2026, reflecting a compound annual growth rate (CAGR) of 17.9%. This historical growth can be attributed to factors such as the increasing prevalence of allergic skin conditions, broader utilization of antihistamines, the expansion of dermatology treatment services, rising awareness of chronic urticaria, and the availability of prescription therapies.

The urticaria market is anticipated to experience substantial expansion over the next few years. It is projected to escalate to $10.71 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 17.5%. This growth during the forecast period is fueled by the increasing adoption of biologic treatments, a rising demand for long-acting therapies, a growing emphasis on immune-modulating drugs, the expansion of specialty dermatology clinics, and heightened investment in allergy and immunology research. Noteworthy trends for this period include the increased development of biologic and monoclonal antibody therapies, the growing use of personalized treatment approaches, a rising focus on chronic urticaria management, the expansion of advanced antihistamine formulations, and an enhanced emphasis on long-term disease control.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=23554&type=smp

What Factors Are Contributing To The Growth Of The Urticaria Market?

Enhanced understanding and management of skin diseases are projected to stimulate the expansion of the urticaria market moving ahead. Rising levels of pollution contribute to a greater prevalence of skin allergies and related conditions, thereby increasing the need for better awareness and sophisticated treatment options. Urticaria plays a role in promoting skin disease awareness and treatment through its demonstration of immune system reactions, fostering scientific investigation, improving diagnostic methods, and furthering the development of specific therapies. An example of this urgency is a report from February 2024 by The Skin Cancer Foundation, a US-based nonprofit organization, which stated that 1 in 5 Americans will develop skin cancer by age 70, and more than 2 deaths from it happen every hour in the U.S. This information underscores the critical necessity for preventative actions, given that experiencing five or more sunburns doubles an individual’s risk of melanoma. Consequently, heightened awareness and improved treatment for skin diseases are propelling the expansion of the urticaria market.

How Is Segmentation Applied In The Urticaria Market Segment Analysis?

The urticaria market covered in this report is segmented –

1) By Type: Acute Urticaria, Chronic Urticaria

2) By Drug Class: Antihistamines, Anti-inflammation Medications, Antidepressants, Monoclonal Antibodies, Other Drug Classes

3) By Route of Administration: Oral, Parenteral, Other Routes Of Administration

4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

5) By End-Users: Hospitals, Homecare, Specialty Clinics, Other End-Users

Subsegments:

1) By Acute Urticaria: Allergic Urticaria, Infectious Urticaria, Drug-Induced Urticaria, Contact Urticaria

2) By Chronic Urticaria: Chronic Spontaneous Urticaria (CSU), Chronic Inducible Urticaria (CIndU)

What Trends Are Shaping The Future Of The Urticaria Market?

Key companies in the urticaria market are concentrating on developing novel solutions, such as mast cell inhibitor antibodies, to create an advanced therapeutic option for managing chronic spontaneous urticaria by targeting mast cell activation. A mast cell inhibitor antibody is a targeted monoclonal antibody designed to block the activation or degranulation of mast cells by inhibiting specific receptors or signaling pathways, thereby diminishing allergic reactions, inflammation, and other mast cell-mediated disorders. For example, in May 2024, Allakos Inc., a US-based biotechnology company, announced the commencement of a Phase 1 clinical trial for AK006, intended for the treatment of chronic spontaneous urticaria (CSU). This innovative therapy addresses both IgE-dependent and IgE-independent mast cell activation pathways, offering the potential for broader effectiveness in patients who are refractory to antihistamines or prior biologic treatments. By selectively inhibiting mast cell activity through the Siglec-6 receptor, AK006 aims to provide a more comprehensive and lasting solution for CSU management, marking a significant progression in urticaria treatment and immunotherapy research.

Who Are The Companies Participating In The Urticaria Market Environment?

Major companies operating in the urticaria market are Sanofi S.A., Novartis AG, GlaxoSmithKline PLC, Roche Holding AG, Teva Pharmaceutical Industries Ltd, Sun Pharmaceutical Industries Ltd, Incyte Corporation, Kyowa Kirin Co. Ltd, Argenx SE, Allakos Inc, AstraZeneca plc, Kiniksa Pharmaceuticals Ltd, United BioPharma Inc, Celldex Therapeutics Inc, Yuhan Corporation, Hangzhou Highlightll Pharmaceutical Co Ltd, Evommune Inc, Rapt Therapeutics Inc, Enanta Pharmaceuticals Inc, UCB Pharma

Get The Full Urticaria Market Report:

https://www.thebusinessresearchcompany.com/report/urticaria-global-market-report

Which Region Dominates The Urticaria Market By Market Share?

North America was the largest region in the urticaria market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the urticaria market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Urticaria Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/urticaria-global-market-report

Browse Through More Reports Similar to the Global Urticaria Market 2026, By The Business Research Company

Dermatitis Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/dermatitis-drugs-global-market-report

Ursolic Acid Market Report

https://www.thebusinessresearchcompany.com/report/ursolic-acid-global-market-report

Allergic Rhinitis Market Report

https://www.thebusinessresearchcompany.com/report/allergic-rhinitis-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795